Search: (WFRF:(Fritsche A)) srt2:(2015-2019) >
Intradermal deliver...
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes
-
- Gan, Li-Ming, 1969 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
Lagerstrom-Fermer, M. (author)
-
Carlsson, L. G. (author)
-
show more...
-
Arfvidsson, C. (author)
-
Egnell, A. C. (author)
-
Rudvik, A. (author)
-
Kjaer, M. (author)
-
Collen, A. (author)
-
Thompson, J. D. (author)
-
Joyal, J. (author)
-
Chialda, L. (author)
-
Koernicke, T. (author)
-
Fuhr, R. (author)
-
- Chien, K. R. (author)
- Karolinska Institutet
-
Fritsche-Danielson, R. (author)
-
show less...
-
(creator_code:org_t)
- 2019-02-20
- 2019
- English.
-
In: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10
- Related links:
-
https://www.nature.c...
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Chemically modified mRNA is an efficient, biocompatible modality for therapeutic protein expression. We report a first-time-in-human study of this modality, aiming to evaluate safety and potential therapeutic effects. Men with type 2 diabetes mellitus (T2DM) received intradermal injections of modified mRNA encoding vascular endothelial growth factor A (VEGF-A) or buffered saline placebo (ethical obligations precluded use of a non-translatable mRNA control) at randomized sites on the forearm. The only causally treatment-related adverse events were mild injection-site reactions. Skin microdialysis revealed elevated VEGF-A protein levels at mRNA-treated sites versus placebo-treated sites from about 4-24 hours post-administration. Enhancements in basal skin blood flow at 4 hours and 7 days post-administration were detected using laser Doppler fluximetry and imaging. Intradermal VEGF-A mRNA was well tolerated and led to local functional VEGF-A protein expression and transient skin blood flow enhancement in men with T2DM. VEGF-A mRNA may have therapeutic potential for regenerative angiogenesis.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- cardiovascular gene-therapy
- endothelial growth-factor
- foot
- angiogenesis
- infarction
- injection
- vaccines
- Science & Technology - Other Topics
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Gan, Li-Ming, 19 ...
-
Lagerstrom-Ferme ...
-
Carlsson, L. G.
-
Arfvidsson, C.
-
Egnell, A. C.
-
Rudvik, A.
-
show more...
-
Kjaer, M.
-
Collen, A.
-
Thompson, J. D.
-
Joyal, J.
-
Chialda, L.
-
Koernicke, T.
-
Fuhr, R.
-
Chien, K. R.
-
Fritsche-Daniels ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
Nature Communica ...
- By the university
-
University of Gothenburg
-
Karolinska Institutet